Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)
Clinical trial NCT07712588 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07712588
- Sponsor
- Dizal Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2031-01-01
- Enrollment
- 880
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.